` Comparison: 6LJ vs ATXS - Alpha Spread

M
6LJ
vs
ATXS

Over the past 12 months, 6LJ has underperformed ATXS, delivering a return of 0% compared to the ATXS's +89 718% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
6LJ
ATXS
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

M
6LJ Intrinsic Value
Not Available
ATXS Intrinsic Value
0.16 USD
Overvaluation 100%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
M
Matinas BioPharma Holdings Inc
F:6LJ
2.69 EUR
Astria Therapeutics Inc
NASDAQ:ATXS
5 784.3 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
6LJ, ATXS

6LJ
ATXS
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
M
Matinas BioPharma Holdings Inc
Revenue
Astria Therapeutics Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
6LJ, ATXS

6LJ
ATXS
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
M
Matinas BioPharma Holdings Inc
F:6LJ
Astria Therapeutics Inc
NASDAQ:ATXS
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

6LJ
0%
ATXS
0%

Operating Margin

6LJ
0%
ATXS
-19 335.7%

Net Margin

6LJ
0%
ATXS
-17 568%

FCF Margin

6LJ
0%
ATXS
-17 042.9%

ROE

6LJ
-134.1%
ATXS
-43.1%

ROA

6LJ
-100.3%
ATXS
-39.2%

ROIC

6LJ
-201.9%
ATXS
-462.1%

ROCE

6LJ
-92.9%
ATXS
-45.9%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
6LJ, ATXS

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
6LJ, ATXS

Loading
6LJ
ATXS
Difference
www.alphaspread.com

Performance By Year
6LJ, ATXS

Loading
6LJ
ATXS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 6LJ to other stocks
PNEXF
Pharnext SCA
More expensive
vs 6LJ
ABBV
Abbvie Inc
Cheaper
vs 6LJ
AMGN
Amgen Inc
Cheaper
vs 6LJ
GILD
Gilead Sciences Inc
Cheaper
vs 6LJ
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett